Episode 130: Oncology and Retina: Follow the Drug Spend, With Jeanne Proia

Episode 130: Oncology and Retina: Follow the Drug Spend, With Jeanne Proia

May 6, 2026 · 21 min · Episode 130

About this episode

Jeanne Proia discusses the significant drug spend in oncology and retina, and the evolving ecosystem around it.

Oncology commands roughly 40% of the national drug spend. Retina is close behind. “If you follow the drug spend, you’ll find that the distributors are really building an ecosystem around it,” says Jeanne Proia , managing director at Cross Keys Capital and president of its healthcare services group. In this conversation with McGuireWoods partner and host Geoff Cockrell , Jeanne unpacks the market. Unlike traditional PE deals, she says, these transactions leave physicians holding their own equity inside a long-term MSO relationship, trading the second bite at the apple for cash upfront and taking the risk off. As she explains: “They’re able to bring a lot more synergies just because they’re getting to be bigger and bigger, and they can use that money to support all the synergies, whether it’s clinical trials, recruiting or RCM.” Connect and Learn More ☑️ Jeanne Proia | LinkedIn ☑️ Cross Keys Capital | LinkedIn ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you…

People in this episode

Host: Geoff Cockrell

Guest: Jeanne Proia

Topics covered

Keywords

Mentioned in this episode

Organizations: Cross Keys Capital, McGuireWoods

More episodes of The Corner Series

Explore listener stats, chart rankings, contacts and more on the The Corner Series podcast page.